Anti-malarial shows promise in human clinical study
Monday, March 11, 2019 - 14:41
in Health & Medicine
An experimental drug, called DSM265, cured seven volunteers of a Plasmodium falciparum infection, a malaria parasite that is a major cause of morbidity and mortality worldwide. The goal of this research is to find a cure for malaria with a single dose, and ultimately, eradicate the parasite.